Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Vancomycin-resistant enterococci in Spanish hospitals: the experience of official network for the surveillance of resistant microorganisms RedLabRA, 2023-2024.

Created on 13 Nov 2026

Authors

Javier E Cañada-García, Sara Pérez de Madrid, Estela Giménez Quiles, María Pilar Ortega-Lafont, María Dolores Tirado-Balaguer, Luis López-Urrutia, Esther Viedma-Moreno, Marta Hernández-García, Nieves Larrosa-Escartín, Julia Serrano-Lobo, Ignasi Roca, Jordi Càmara, Diego García Martínez-de-Artola, Ana Isabel López-Calleja, Paloma Merino Amador, Cristina Seral, Lorena López-Cerero, Fernando Lázaro-Perona, Ferran Navarro, Fernando González-Candelas, María Pérez-Vázquez, Jesús Oteo-Iglesias, Spanish RedLabRA Network Study Group

Published in

Frontiers in public health. Volume 14. Pages 1966902. Epub Oct 29, 2026.

Abstract

RedLabRA is a network of microbiology laboratories for the genomic surveillance of antibiotic resistance. The aim of this study was to describe the actions undertaken by RedLabRA in response to an increase of vancomycin-resistant enterococci (VRE) in some Spanish regions.
RedLabRA designed a VRE surveillance organized in two phases: (1) a questionnaire to assess risk perception of VRE among the network's Level 2 laboratories (LN2), and (2) collection of cases detected between April 2023 and March 2024, followed by WGS of a sample of vancomycin-resistant Enterococcus faecium (VREfm) isolates to investigate interregional dissemination. WGS was performed using the Illumina platform; MLST (PubMLST.org scheme), cgMLST and phylogenetic relationships (Ridom SeqSphere+ v3.5.0), and resistome (Resfinder 4.7.2) were analysed.
Nine of the 17 autonomous communities defined a priority scenario of VRE. 31 LN2 reported 1,958 VRE cases from 86 hospitals across 12 autonomous communities and the autonomous city Ceuta. The predominant species was E. faecium (97.1%). 317 VREfm isolates were included for WGS: 211 (66.6%) carried the vanA gene, 90 (28.4%) vanB, and 16 (5%) both genes. ST117 (34.7%), ST80 (27.1%), or ST1421 (25.6%) predominated. Using cgMLST (1,423 genes, cutoff of 5 alleles), 45 VREfm clusters were identified, of which eight involved at least three hospitals and were inter-regional. 51 (16.1%) isolates carried linezolid resistance mechanisms, mainly optrA+cfrD.
VREfm had a highly uneven impact across Spanish regions. The inter-regional presence of VREfm isolates with high genetic similarity belonging to ST1421, ST117, and ST80 clones was detected. The emergence of E. faecium isolates carrying genes conferring resistance to vancomycin and linezolid requires ongoing surveillance.

PMID:
43021967
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement